Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein

BACKGROUND: Recently, the Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 infection has spread rapidly around the world, becoming a new global pandemic disease. Nucleic acid detection is the primary method for clinical diagnosis of SARS-CoV-2 infection, with the addition of antibody and ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ye, Xia, Chuan, Zeng, Xuan, Qiu, Yilan, Liao, Minjing, Jiang, Qing, Quan, Meifang, Liu, Rushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801064/
https://www.ncbi.nlm.nih.gov/pubmed/35108595
http://dx.doi.org/10.1016/j.jviromet.2022.114486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801064/
https://www.ncbi.nlm.nih.gov/pubmed/35108595
http://dx.doi.org/10.1016/j.jviromet.2022.114486

Ejemplares similares